Rep. David J. Taylor (House) has filed a Periodic Transaction Report disclosing a sale of Amgen Inc. common stock (AMGN), made personally by the member and reported as held through Dave’s IRA @ Schwab (Home Grown). The transaction, dated August 26, 2026, falls in the disclosed range of $1,001 to $15,000, the standard bracket used in STOCK Act filings to indicate a general size rather than an exact dollar figure.
Under the STOCK Act, members of Congress and certain executive branch officials are required to publicly report transactions in stocks, bonds, and other covered securities within 45 days of the trade date. These filings are not evidence of wrongdoing; they exist specifically so the public can see when officials or their household accounts are trading in securities of publicly traded companies, without implying any judgment on the timing or rationale behind a given trade.
A Notable Overlap With Insider Selling
What makes this filing worth flagging is its proximity to another sale of the same stock. Company insider Khosla Rachna also sold shares of AMGN, offloading a stake valued at $203,575 on August 13, 2026. That transaction occurred just 13 days before Rep. Taylor’s disclosed sale, placing both moves inside the same 30-day window. Our classification tags this as a ‘congress sale’ signal, and the near-simultaneous insider sale adds a layer of context that readers tracking Amgen-related disclosures may find relevant, even though there is no indication the two transactions are connected.
Amgen has previously appeared in congressional trading disclosures tracked on this site. Rep. Julia Letlow, for instance, has filed multiple AMGN-related reports, including one detailed in our earlier coverage, Julia Letlow Discloses AMGN Sale, Filed 265 Days Late, which highlighted how reporting delays can sometimes stretch well beyond the 45-day window required by law. Rep. Taylor’s filing does not appear to carry that same delay issue based on the facts disclosed here, but it adds to a growing pattern of congressional activity around this particular healthcare stock.
For now, the publicly available record shows a modest-sized sale by Rep. Taylor through a Schwab-held IRA account, occurring in the same general timeframe as a much larger insider sale by Khosla Rachna. Readers interested in following how these disclosures accumulate over time, and whether additional Amgen-related filings emerge from other members of Congress, can expect continued tracking of this ticker on whoisbuyingnow.com as new Periodic Transaction Reports become public.